Modeling and Simulation Archives

Case Study

Streamlining Biotech Data Compliance and Management with Certara’s Phoenix Hosted

Discover how Certara's Phoenix Hosted streamlined data compliance and management for a biotech company, enhancing…

CertaraMay 31, 2024

On-Demand Webinar

What is new in Phoenix 8.5?

Discover the latest advancements and enhancements in Phoenix version 8.5. Watch the webinar to learn…

CertaraFebruary 26, 2024

Publication

Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator

The Simcyp Simulator is a software platform for population physiologically-based pharmacokinetic (PBPK) modeling and simulation.…

CertaraFebruary 23, 2024

On-Demand Webinar

Streamlining Your NCA Workflow

PK analysis intended for submission contends with many data and compliance challenges. To work efficiently,…

CertaraJanuary 18, 2024

Publication

Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome

Madin–Darby canine kidney (MDCK) cells are widely used to study epithelial cell functionality. Their low…

CertaraJune 28, 2023

Case Study

Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…

CertaraJune 1, 2023

Case Study

Using Modeling & Simulation to Develop a Dosing Regimen for a Bispecific Antibody for Pediatric Cancer

Bispecific antibodies are an emerging class of antibodies developed in recent years that provide new…

CertaraJanuary 23, 2023

Case Study

Simcyp Simulator Helps Optimize Drug Dosing in Adults & Adolescents with Orphan Disease

Congenital adrenal hyperplasia (CAH) affects about 400,000 patients worldwide. Current therapy for CAH uses a…

CertaraJune 6, 2022

Case Study

Bridging Formulations of Quetiapine for Children with Schizophrenia or Bipolar Disorder

Quetiapine is an atypical antipsychotic for treating schizophrenia, bipolar depression, bipolar mania that helps to…

CertaraAugust 26, 2021

Case Study

Aripiprazole lauroxil: PBPK for Dosing Regimen and DDI Identification

Aripiprazole lauroxil (Aristada®) was approved by the FDA for treating schizophrenia in adults in October…

CertaraAugust 12, 2021

Modeling and Simulation

Streamlining Biotech Data Compliance and Management with Certara’s Phoenix Hosted

What is new in Phoenix 8.5?

Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator

Streamlining Your NCA Workflow

Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome

Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

Using Modeling & Simulation to Develop a Dosing Regimen for a Bispecific Antibody for Pediatric Cancer

Simcyp Simulator Helps Optimize Drug Dosing in Adults & Adolescents with Orphan Disease

Bridging Formulations of Quetiapine for Children with Schizophrenia or Bipolar Disorder

Aripiprazole lauroxil: PBPK for Dosing Regimen and DDI Identification

Newsletter sign up

Quick links

Solutions

Contact